Clinical issues in the prophylaxis, diagnosis, and treatment of anthrax

Emerging Infectious Diseases

Volumn 8, Issue 2, 2002, Pages 222-225

  Bell, David M ^a   Kozarsky, Phyllis E ^a   Stephens, David S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MACROLIDE; MEROPENEM; PENICILLIN G; QUINOLONE DERIVATIVE; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; BACILLUS ANTHRACIS; CONFERENCE PAPER; DRUG EFFICACY; HUMAN; MONKEY; NONHUMAN; POLYMERASE CHAIN REACTION;

EID: 0036197477     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0802.01-0521     Document Type: Conference Paper

References (13)

1. Prescription drug products; doxycycline and penicillin G procaine administration for inhalational anthrax (post-exposure)
2. Postexposure prophylaxis against inhalation anthrax
3. Use of anthrax vaccine in the United States: Recommendations of the Advisory Committee on ImmunizatiOn Practices (ACIP)
4. Update: Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001
5. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis
6. Update: Interim recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax
7. Observations on the prophylaxis of experimental pulmonary anthrax in the monkey
8. The Sverdlovsk anthrax outbreak of 1979
9. Additional options for preventive treatment for persons exposed to inhalational anthrax
10. Interim guidelines for investigation of and response to Bacillus anthracis exposures
11. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States
12. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy
13. Anthrax